EUVIMEDEUVIMED entdecken
Crossref

Polymorphism Study on SLC30A8 and Its Association with Type 2 Diabetes

M Vignesh, T Sangeetha, T Varsha

Recent Advances in Biology and Medicine · 2016

DOI: 10.18639/rabm.2016.02.335391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Recent Advances in Biology and Medicine, 2016. Verfasst von M Vignesh und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is one of the threatening disorders in the world. It affects people of all ages. Type 2 diabetes mellitus is a condition in which the glucose level in the blood is elevated due to improper function of the secretion of insulin from beta cells of the pancreas. It is a multifactorial disease because it is caused by both environmental and hereditary factors. One of the genes which play an important role in type 2 diabetes mellitus is SLC30A8 which encodes for zinc transporter ZnT8. The common polymorphic site for SLC30A8 is rs13266634. This single-nucleotide polymorphism leads to type 2 diabetes mellitus by replacing the arginine residue with tryptophan residue. This review mainly focuses on the polymorphic studies in the gene SLC30A8 and its association with type 2 diabetes mellitus.

Zitieren

APA

Vignesh, M., Sangeetha, T., & Varsha, T. (2016). Polymorphism Study on SLC30A8 and Its Association with Type 2 Diabetes. Recent Advances in Biology and Medicine. https://doi.org/10.18639/rabm.2016.02.335391

Vancouver

Vignesh M, Sangeetha T, Varsha T. Polymorphism Study on SLC30A8 and Its Association with Type 2 Diabetes. Recent Advances in Biology and Medicine. 2016. doi:10.18639/rabm.2016.02.335391

BibTeX
@article{Vignesh2016,
  author = {Vignesh, M and Sangeetha, T and Varsha, T},
  title = {Polymorphism Study on SLC30A8 and Its Association with Type 2 Diabetes},
  journal = {Recent Advances in Biology and Medicine},
  year = {2016},
  doi = {10.18639/rabm.2016.02.335391}
}
Kostenlos starten →